Drug-Pricing Bill Advances to Full Senate With Uncertain Fate

Bookmark
(Bloomberg) -- A key Senate panel voted to approve legislation that would cap how much pharmaceutical companies can raise prices, though a lack of overwhelming Republican support leaves its fate in...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.